Skip to main content
Log in

Haloperidol for severe anorexia nervosa restricting type with delusional body image disturbance: a nine-case chart review

  • Brief Report
  • Published:
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity Aims and scope Submit manuscript

Abstract

Here we report on a case series chart review conducted on nine severe and treatment-resistant patients with anorexia nervosa, body mass index <13 kg/m2, and a delusional body image disturbance. Patients received low doses of haloperidol during hospitalization. Haloperidol was well tolerated. The delusional body image disturbance and the drive for thinness were subjectively perceived as less intense. BMI increased from the initial 12.2 ± 0.5 to 16.0 ± 1.5 kg/m2. Mean pulse rate and blood pressure did not change significantly from admission to discharge (66 ± 11.6 bpm; 91/56 mmHg vs 77 ± 12.0 bpm; 102/66 mmHg). Mean of QTc, available from electrocardiograms performed during hospitalization, was 413 ± 38.5 ms (range 342–469 ms). Further investigations are warranted to elucidate clinical usefulness and safety of low doses of haloperidol for patients with treatment-resistant anorexia and delusional body image disturbance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Frieling H, Römer KD, Scholz S et al (2010) Epigenetic dysregulation of dopaminergic genes in eating disorders. Int J Eat Disord 43(7):577–583

    Article  PubMed  Google Scholar 

  2. Ramacciotti CE, Dell’Osso L, Paoli RA et al (2002) Characteristics of Eating Disorder patients without a drive for thinness. Int J Eat Disord 32(2):206–212

    Article  PubMed  Google Scholar 

  3. Cassano GB, Miniati M, Pini S et al (2003) Six-month open trial of haloperidol as adjunctive treatment for anorexia nervosa: a preliminary report. Int J Eat Disord 33(2):172–177

    Article  PubMed  Google Scholar 

  4. Lebow J, Sim LA, Erwin PJ, Murad MH (2013) The effect of atypical antipsychotic medications in individuals with anorexia nervosa: a systematic review and metaanalysis. Int J Eat Disord 46(4):332–339

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors gratefully acknowledge the assistance of Dr. Giulia Gray of the University of Pisa, Italy, for the English revision.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Liliana Dell’Osso.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mauri, M., Miniati, M., Mariani, M.G. et al. Haloperidol for severe anorexia nervosa restricting type with delusional body image disturbance: a nine-case chart review. Eat Weight Disord 18, 329–332 (2013). https://doi.org/10.1007/s40519-013-0052-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40519-013-0052-9

Keywords

Navigation